Linking molecular therapeutics to molecular diagnostics: inhibition of the FRAP/RAFT/TOR component of the PI3K pathway preferentially blocks PTEN mutant cells in vitro and in vivo.

Source:http://linkedlifedata.com/resource/pubmed/id/11526226

Proc. Natl. Acad. Sci. U.S.A. 2001 Aug 28 98 18 10031-3

Download in:

View as

General Info

PMID
11526226